Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Medpace
MEDP
$16.5B
| $4.09M | ﹤0.01% |
16,897
-7,583
| -31% | -$1.94M |
|
1427
e.l.f. Beauty
ELF
$5.8B
| $4.09M | ﹤0.01% |
37,220
-1,713
| -4% | -$208K |
|
1428
Greif
GEF
$5.04B
| $4.08M | ﹤0.01% |
61,087
-467
| -0.8% | -$33.1K |
|
1429
PUT
Bank OZK
OZK
$5.61B
| $4.08M | ﹤0.01% |
+110,000
| New | +$4.46M |
|
1430
Essent Group
ESNT
$6.33B
| $4.07M | ﹤0.01% |
86,167
-15,538
| -15% | -$770K |
|
1431
Axos Financial
AX
$5.68B
| $4.07M | ﹤0.01% |
107,608
-6,002
| -5% | -$254K |
|
1432
SunCoke Energy
SXC
$797M
| $4.07M | ﹤0.01% |
400,784
+292,683
| +271% | +$2.65M |
|
1433
Sonos
SONO
$1.85B
| $4.07M | ﹤0.01% |
314,891
+20,902
| +7% | +$310K |
|
1434
Alight
ALIT
$407M
| $4.05M | ﹤0.01% |
28,545
+11,192
| +64% | +$1.88M |
|
|
WCC
1435
WESCO International
WCC
$17.7B
| $4.03M | ﹤0.01% |
28,036
-5,589
| -17% | -$902K |
|
1436
HealthEquity
HQY
$8.75B
| $4.03M | ﹤0.01% |
55,140
-8,041
| -13% | -$543K |
|
1437
Blackstone Mortgage Trust
BXMT
$2.38B
| $4.03M | ﹤0.01% |
185,064
+113,249
| +158% | +$2.51M |
|
1438
PUT
Allstate
ALL
$67.5B
| $4.01M | ﹤0.01% |
+36,000
| New | +$3.93M |
|
1439
Novavax
NVAX
$1.31B
| $4.01M | ﹤0.01% |
553,790
+12,235
| +2% | +$97.8K |
|
1440
First Hawaiian
FHB
$3.35B
| $3.99M | ﹤0.01% |
221,082
-15,877
| -7% | -$306K |
|
|
CLVT.PRA
1441
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $3.99M | ﹤0.01% |
136,333
+41,428
| +44% | +$1.44M |
|
1442
BioNTech
BNTX
$23.5B
| $3.98M | ﹤0.01% |
36,679
-36,548
| -50% | -$4.04M |
|
|
NVEI
1443
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $3.98M | ﹤0.01% |
265,514
+255,365
| +2,516% | +$5.92M |
|
|
PPLI
1444
People Inc
PPLI
$3.1B
| $3.98M | ﹤0.01% |
96,163
-539
| -0.6% | -$26.1K |
|
1445
Toast
TOST
$19.9B
| $3.96M | ﹤0.01% |
211,671
+2,086
| +1% | +$45.3K |
|
1446
Credit Acceptance
CACC
$6.08B
| $3.96M | ﹤0.01% |
8,610
+6,838
| +386% | +$3.46M |
|
1447
Fulton Financial
FULT
$4.64B
| $3.96M | ﹤0.01% |
326,770
+6,314
| +2% | +$82.8K |
|
1448
CALL
Gilead Sciences
GILD
$165B
| $3.96M | ﹤0.01% |
52,800
-121,600
| -70% | -$9.35M |
|
1449
PUT
Jefferies Financial Group
JEF
$13.1B
| $3.96M | ﹤0.01% |
+108,000
| New | +$3.87M |
|
1450
Weatherford International
WFRD
$6.22B
| $3.96M | ﹤0.01% |
43,793
+17,265
| +65% | +$1.46M |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.